Literature DB >> 23588605

Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation.

A G Rigopoulos1, B Pfeiffer, H Seggewiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23588605     DOI： 10.1007/s00059-013-3794-2

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  11 in total

1.  Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.

Authors:  L Faber; H Seggewiss; P Ziemssen; U Gleichmann
Journal:  Catheter Cardiovasc Interv       Date:  1999-08       Impact factor: 2.692

2.  Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy.

Authors:  M Singh; W D Edwards; D R Holmes; A J Tajil; R A Nishimura
Journal:  Mayo Clin Proc       Date:  2001-08       Impact factor: 7.616

Review 3.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

4.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

5.  Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.

Authors:  L Faber; P Ziemssen; H Seggewiss
Journal:  J Am Soc Echocardiogr       Date:  2000-12       Impact factor: 5.251

6.  [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].

Authors:  B Pfeiffer; A Rigopoulos; H Seggewiß
Journal:  Dtsch Med Wochenschr       Date:  2012-10-02       Impact factor: 0.628

7.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

8.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.

Authors:  L Faber; H Seggewiss; U Gleichmann
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

9.  Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.

Authors:  Lothar Faber; Hubert Seggewiss; Dirk Welge; Dieter Fassbender; Henning K Schmidt; Ulrich Gleichmann; Dieter Horstkotte
Journal:  Eur J Echocardiogr       Date:  2004-10

Review 10.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007
View more
  1 in total

Review 1.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.